Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8231598 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
Hypofractionated SBRT can be delivered quickly and effectively in patients with nonmetastatic, locally advanced, unresectable pancreatic cancer with acceptable side effects and minimal interference with gemcitabine chemotherapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Anand M.D., Sanjay M.D., Ph.D., Michael M.D., Rebecca M.D., M.P.H., Douglas M.D., Mandeep M.D., Darren M.D., Mark M.D., Charles M.D.,